Utilization of circulating tumor DNA (ctDNA) analysis to detect minimal residual disease post-surgery and disease progression in metastatic thymic tumors

被引：0
|
作者：
Ardeshir-Larijani, Fatemeh
Ravichandran, Karthik Raja
Schneider, Bryan P.
Radovich, Milan
Maniar, Rohan
Masood, Ashiq
Kesler, Kenneth
Loehrer, Patrick J.
机构：
[1] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA
[2] Indiana Univ Sch Med, Indianapolis, IN USA
[3] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN USA
[4] Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA
[5] Indiana Univ, Dept Cardiosurg, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8598
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Circulating tumor DNA (ctDNA) utilizing a high-sensitivity panel to detect minimal residual disease post liver hepatectomy and predict disease recurrence.
    Overman, Michael J.
    Vauthey, Jean-Nicolas
    Aloia, Thomas A.
    Conrad, Claudius
    Chun, Yun Shin
    Pereira, Allan Andresson Lima
    Jiang, Zhiqin
    Crosby, Shadarra
    Wei, Steven
    Raghav, Kanwal Pratap Singh
    Morris, Van Karlyle
    Tan, Michelle
    Maslan, Annie
    Talasaz, AmirAli
    Mortimer, Stefanie
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Longitudinal evaluation of circulating tumor DNA (ctDNA) as a prognostic biomarker to detect minimal residual disease (MRD) in testicular cancer
    Hassoun, Rebecca
    Ben-David, Reuben
    Sfakianos, John P.
    Laliotis, George
    Cary, Clint
    Masterson, Timothy A.
    Rivero-Hinojosa, Samuel
    Manage, Kevin
    Dutta, Punashi
    Tillu, Neeraja
    Cumarasamy, Shivaram
    King, Jennifer
    Rich, Jordan
    Rock, Adam
    Dorff, Tanya B.
    ElNaggar, Adam
    Liu, Minetta C.
    Einhorn, Lawrence H.
    Chehrazi-Raffle, Alex
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Tissue-informed ctDNA MRD assay detects post-surgery minimal residual disease in HCC patients
    Hu, Jie
    Tang, Haoran
    Xie, Feng
    Zhang, Yue
    Jia, Shidong
    Zhou, Jian
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Circulating Tumor DNA as a Marker of Minimal Residual Disease
    Fangman, Ben
    Raghav, Kanwal
    Kopetz, Scott
    ONCOLOGY-NEW YORK, 2022, 36 (10): : 600 - 603
  • [5] Circulating Tumor DNA Analysis on Metastatic Prostate Cancer with Disease Progression
    Bang, Sungun
    Won, Dongju
    Shin, Saeam
    Cho, Kang Su
    Park, Jae Won
    Lee, Jongsoo
    Choi, Young Deuk
    Kang, Suwan
    Lee, Seung-Tae
    Choi, Jong Rak
    Han, Hyunho
    CANCERS, 2023, 15 (15)
  • [6] CIRCULATING TUMOR DNA ANALYSIS ON METASTATIC PROSTATE CANCER WITH DISEASE PROGRESSION
    Bang, Sungun
    Han, Hyun Ho
    Cho, Kang Su
    Park, Jae Won
    Choi, Young Deuk
    Shin, Saeam
    Won, Dong Ju
    JOURNAL OF UROLOGY, 2023, 209 : E763 - E763
  • [7] Circulating tumor DNA analysis on metastatic prostate cancer with disease progression
    Bang, S.
    Han, H. H.
    Cho, K. S.
    Park, J. W.
    Choi, Y. D.
    Shin, S.
    Won, D. J.
    EUROPEAN UROLOGY, 2023, 83
  • [8] Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease
    Moding, Everett J.
    Nabet, Barzin Y.
    Alizadeh, Ash A.
    Diehn, Maximilian
    CANCER DISCOVERY, 2021, 11 (12) : 2968 - 2986
  • [9] Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival
    Murray, David H.
    Symondsz, Erin L.
    Young, Graeme P.
    Byrne, Susan
    Rabbite, Philippa
    Roy, Amitesh
    Cornthwaite, Kathryn
    Karapetis, Christos S.
    Pedersen, Susanne K.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (09) : 1741 - 1750
  • [10] Using ctDNA to Detect Minimal Residual Disease after Surgery in Resectable Lung Cancer
    Huang, J.
    Zhang, M.
    Mou, Y.
    Chen, R.
    Xia, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S279 - S279
12345